All about COVID-19

How an asymptomatic player turned super-spreader

Tricky situation: Among 19 of 21 persons infected, symptoms developed an average of 2.3 days after collection of the test-positive sample.   | Photo Credit: Bill Oxford

The importance of testing asymptomatic persons for novel coronavirus and the import of mitigation strategies to decrease the spread of the virus have been highlighted in a super-spreading event involving team A that participated in the Major League Baseball matches in Philadelphia in end-June. A single index player spread the virus to 20 other players of his team and to one employee of team B. The results were published in the Morbidity and Mortality Weekly Report (MMWR).

Health protocols

The Major League Baseball developed new health and safety protocols before the July 24 start of the 2020 season based on CDC’s COVID-19 mitigation recommendations related to events and gatherings. These include non-pharmaceutical interventions such as mask wearing and social distancing, frequent (every other day) testing for rapid identification of people infected with the virus before they exhibited symptoms and isolation of the infected and quarantining of close contacts. In addition, the games were played without spectators.

Despite multiple mitigation strategies, including that testing of each player every alternate day was in place, the spread of the virus to other players could not be prevented. This was primarily because the virus spread during the asymptomatic phase of infection. To prevent further spread by asymptomatic players, the Major League Baseball initiated daily testing instead of alternate day testing for all players belonging to team A and B for the duration of the outbreak. Frequent testing helped identify players infected with virus days before they started showing symptoms. “Among the 19 of 21 persons with COVID-19 who were symptomatic, symptoms developed an average of 2.3 days after collection of the test-positive sample,” says the team led by Dr. Meghan Murray from the Epidemic Intelligence Service, CDC which investigated the super-spreading event, in the paper in MMWR.

The index case, who was still asymptomatic, received a positive test result on day four of the games before a three-game series with team B. The result was based on a sample collected on day two. The index case was immediately isolated and all players of team A and staff members who were in close contact with the index cases were tested.

On day five, after the second game with team B, three more players of team A tested positive. The following day, an additional eight team A players and staff member of team B tested positive. In the following days, eight more players of team A tested positive.

Genome sequencing revealed that 17 of the 18 samples that were sequenced had a single nucleotide variant, revealing that the super-spreading event was from a single index case.

Outside the field

Despite team A playing five games in all, spending a cumulative 11 hours on the field, no player from team B or team C, coaches or umpires became infected. According to the study, the virus spread had occurred outside the field. “Interactions outside of on-field play were likely the source of spread, and SARS-CoV-2 transmission risk between baseball teams while on the playing field appeared low,” the authors write. The employee of team B who was infected had apparently closely interacted indoors with team A tier 1 employees who subsequently tested positive.

Additional support

“Social distancing measures have been effective in a variety of settings, and this outbreak provides additional support for their use during sporting events, such as baseball games,” the authors note. Universal mask-wearing policies provided additional protection for team mates. “Consistent adherence to these policies off-field also might have contributed to protecting the communities hosting the games,” they note.


Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Dec 2, 2021 6:32:33 PM | https://www.thehindu.com/sci-tech/science/how-an-asymptomatic-player-turned-super-spreader/article32937219.ece

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
You are reading
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story